Mutation Clearance after Transplantation for Myelodysplastic Syndrome

BACKGROUND: Allogeneic hematopoietic stem-cell transplantation is the only curative treatment for patients with myelodysplastic syndrome (MDS). The molecular predictors of disease progression after transplantation are unclear. METHODS: We sequenced bone marrow and skin samples from 90 adults with MD...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:N Engl J Med
Prif Awduron: Duncavage, Eric J., Jacoby, Meagan A., Chang, Gue Su, Miller, Christopher A., Edwin, Natasha, Shao, Jin, Elliott, Kevin, Robinson, Joshua, Abel, Haley, Fulton, Robert S., Fronick, Catrina C., O’Laughlin, Michelle, Heath, Sharon E., Brendel, Kimberly, Saba, Raya, Wartman, Lukas D., Christopher, Matthew J., Pusic, Iskra, Welch, John S., Uy, Geoffrey L., Link, Daniel C., DiPersio, John F., Westervelt, Peter, Ley, Timothy J., Trinkaus, Kathryn, Graubert, Timothy A., Walter, Matthew J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2018
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6309244/
https://ncbi.nlm.nih.gov/pubmed/30207916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1804714
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg